ConductScience.org, home

Paper8097924

Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.

Dei Cas L and 3 others. Cardiovasc Drugs Ther, 1993. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. Papers, record 8097924. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8097924

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure.
PubMed
Journal
Cardiovasc Drugs Ther
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2019-09-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dei Cas LL
2Metra MM
3Ferrari RR
4Visioli OO

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ExerciseMajor topic
Heart FailureMajor topic
HemodynamicsMajor topic
Neurotransmitter AgentsMajor topic
NisoldipineMajor topic
RestMajor topic
Adult
Aged
Chronic Disease
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12882868Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure.Circulation1987https://conductscience.org/library/papers/2882868PubMed
22808990Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis.J Am Coll Cardiol1989https://conductscience.org/library/papers/2808990PubMed
36488501Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure.Circulation1984https://conductscience.org/library/papers/6488501PubMed
41967559Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.Circulation1990https://conductscience.org/library/papers/1967559PubMed
57415993Hemodynamic effects of nifedipine in congestive heart failure.Am J Cardiol1980https://conductscience.org/library/papers/7415993PubMed
62459547Intravenous nisoldipine in severe congestive heart failure.J Cardiovasc Pharmacol1988https://conductscience.org/library/papers/2459547PubMed
73310565Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure.Am Heart J1987https://conductscience.org/library/papers/3310565PubMed
82242521
A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.
Circulation1990https://conductscience.org/library/papers/2242521PubMed
92880884Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.J Am Coll Cardiol1987https://conductscience.org/library/papers/2880884PubMed
102878602Coronary and systemic hemodynamic effects of intravenous nisoldipine.Am J Cardiol1986https://conductscience.org/library/papers/2878602PubMed
112330899Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure.Am J Cardiol1990https://conductscience.org/library/papers/2330899PubMed
127194077Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).Arzneimittelforschung1980https://conductscience.org/library/papers/7194077PubMed
132688986Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.Circulation1989https://conductscience.org/library/papers/2688986PubMed
146684444Hemodynamic effects of nisoldipine in chronic congestive heart failure.Arzneimittelforschung1983https://conductscience.org/library/papers/6684444PubMed
157261283Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.Circulation1981https://conductscience.org/library/papers/7261283PubMed
161729848Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function.Am Heart J1992https://conductscience.org/library/papers/1729848PubMed
176085356Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.J Cardiovasc Pharmacol1984https://conductscience.org/library/papers/6085356PubMed
186466518Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.Br Heart J1984https://conductscience.org/library/papers/6466518PubMed
193973272Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside.J Am Coll Cardiol1985https://conductscience.org/library/papers/3973272PubMed
206741802Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure.Am J Cardiol1984https://conductscience.org/library/papers/6741802PubMed

See all 44 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
8485072Calcium antagonists for congestive heart failure: is it really one bridge too far to cross?Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8485072PubMed
7947378Cardioselectivity of calcium antagonists.Cardiovasc Drugs Ther1994https://conductscience.org/library/papers/7947378PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8097924

GET https://conductscience.org/api/papers/v1/8097924/references?page=2